on all orders above $200.00

FREE Pills!


for free with every order



Less than in your
local pharmacy

Search by letter:


Enter coupon: (if you have one)

About Emtri

Rating of sales:          


Emtri is beneficial and comfortable for use drug as it contains already three active ingredients allowing to get best results of the anti-retroviral therapy (ART). Lamivudine (3TC) and Stavudine (d4T) are synthetic guanosine nucleoside reverse transcriptase inhibitors (NRTIs), and Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI).


- treatment of human immunodeficiency virus (HIV-1) infection in patients, who have been stabilized on the maintenance regimen of Nevirapine 200 mg twice a day, and have demonstrated adequate tolerability to Nevirapine.

MOA (mechanism of action):

Their mode of action of Lamivudine and Stavudine is to inhibit reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. Nevirapine directly inhibits RT by blocking the RNA-dependent and DNA-dependent DNA polymerase activities. Nevirapine has no effect on HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases α, β, γ or δ). Emtri is not effective against HIV-2.


Treatment should never be start with a full dose of Emtri. Increased risk of serious rash and life-threatening skin reaction if Nevirapine used at full dose in first 14 days.

The 14-day lead-in period with Nevirapine 200 mg daily is recommended as this reduces the frequency of rash.

If rash continues after the 14-day lead-in period, do not increase the dose to 200 mg twice daily. The 200 mg once-daily dosing regimen should not be continued beyond 28 days, at which point an alternative regimen should be sought.

Emtri 30 tablets for patients weighing less than 60 kg: 1 tablet twice daily.

Emtri 40 tablets for patients weighing at least 60 kg: 1 tablet twice daily.

Do not use Emtri in patients who have just initiated therapy with Nevirapine. Initial lead-in dosing of 200 mg Nevirapine once daily for 2 weeks is recommended.

Emtri should not be initiated in women with CD4^^ cell counts greater than 250 cells/mm^3^ or in men with CD4^^ cell counts greater than 400 cells/mm^3^ unless the benefit outweighs the risk.


Patients must be monitored regularly during the first 18 weeks of therapy with Nevirapine to detect potentially life-threatening hepatotoxicity or skin reactions.

HIV can be transmitted through sexual contact with HIV positive partner, blood (e.g., sharing needles, handling blood instruments, receiving blood transfusions, blood products, or organ/tissue transplants that were infected with HIV), childbirth, toiletries (razors and toothbrushes). Therefore, both HIV-positive and HIV-negative individuals are advised to have any kind of sex using a latex or polyurethane condom, avoid sharing needles or other things like toothbrushes or razors. It is important to discuss with doctor the precautions needed to avoid infecting other people as well as take precautions not to get infected.

Women who are HIV-positive must not breastfeed because HIV infection can be passed on to the baby in breast milk.

Take special care if you have moderate or severe liver disease, you have ever had liver disease, including hepatitis B or C, you are seriously overweight (especially if you are a woman), you have severe kidney disease.

Consult doctor before taking if you are taking phenytoin (for treating epilepsy), methadone (as a heroin substitute). Stavudine speeds up the removal of methadone from the body. If you are taking methadone, you will be checked for any withdrawal symptoms. Your methadone dose may need to be re-elevated.

Some people who take Emtri may experience:

- Severe hepatotoxicity, particularly in the first 18 weeks, may develop in patients treated with Nevirapine.

- Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination, including Lamivudine and Stavudine and other anti-retrovirals.

- Severe skin reactions, including fatal cases, may occur in patients treated with Nevirapine. These are Stevens-Johnson syndrome, toxic epidermal necrolysis, and hypersensitivity reactions characterized by rash, constitutional findings and organ dysfunction.

- Pancreatitis, including fatal cases, may occur in patients during therapy when Stavudine was part of a combination regimen that included didanosine in both treatment-naive and treatment-experienced patients, regardless of the degree of immunosuppression.

Missing a dose

If you miss a dose you should take it as soon as you remember about your missing. If it is the time for the next dose you should continue your regular dosing schedule. Do not take a double dose of Emtri to compensate the missed dose.


If an overdose occurs and you are not feeling well, stop taking the medication immediately. You should seek emergency medical attention or contact your healthcare provider immediately.


Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F) and away from excess moisture and heat. Throw away any unused medicine after the expiration date. Keep out of the reach of children.

Side effects

The most common and uncommon side effects associated with Emtri are:

  • headache
  • malaise and fatigue
  • fever or chills
  • nausea
  • diarrhea
  • nausea and vomiting
  • anorexia and/or decreased appetite
  • abdominal pain
  • abdominal cramps
  • dyspepsia
  • neuropathy
  • insomnia and other sleep disorders
  • dizziness
  • depressive disorders
  • nasal signs and symptoms
  • cough
  • skin rashes
  • musculoskeletal pain
  • myalgia
  • arthralgia

Side effects occurrence does not only depend on the medication you are taking, but also on your overall health and other factors.


Emtri is contraindicated in patients who are allergic to Stavudine, Lamivudine, Nevirapine or any of the other ingredients of Emtri.

Do not combine Emtri with other lamivudine-, Stavudine-, or emtricitabine-containing products.

Emtri is contraindicated if you have or have had very low red blood cell count (severe anemia) or very low white blood cell count (neutropenia), kidney disease or liver disease (such as hepatitis), peripheral neuropathy, pancreatitis, hepatitis B or C and, hemophilia, diabetes mellitus, erectile dysfunction.

Emtri is contraindicated in patients who are just starting therapy with Nevirapine. These patients require a lead-in dose of Nevirapine 200 mg once daily.

Nevirapine is contraindicated for use as part of occupational and non-occupational post-exposure prophylaxis (PEP) regimens.

Do not combine Emtri with such medications astemizole or terfenadine (for allergy); amiodarone, bepridil, dronedarone, encainide, flecainide, propafenone, quinidine (used for irregular heartbeats); dihydroergotamine, ergotamine (for migraines); ergonovine, methylergonovine (for stopping excessive bleeding); clorazepate, diazepam, estazolam, flurazepam, triazolam or oral midazolam (help to fall asleep); clozapine, pimozide, (psychiatric drugs); quetiapine (for schizophrenia, bipolar disorder and major depressive disorder); lurasidone (for depression); ranolazine (for chronic chest pain); pethidine, piroxicam, propoxyphene (used to relieve pain); cisapride (for stomach conditions); rifabutin (for certain infections); voriconazole (for fungal infections); simvastatin, lovastatin (for lowering blood cholesterol); alfuzosin (for enlarged prostate); fusidic acid (for bacterial infections); PDE5 inhibitos (sildenafil, avanafil); colchicine (for gout), products containing St John’s wort, tavudine, ribavirin, valproic acid, fluconazole, probenecid, pentamidine, dapsone, pyrimethamine, cotrimoxazole, amphotericin, flucytosine, ganciclovir, valganciclovir, interferon, vincristine, vinblastine, and doxorubicin.

Consult your doctor before taking Emtri if you are pregnant or plan to have a baby.

Women who are HIV-positive must not breastfeed because HIV infection can be passed on to the baby in breast milk.

Q: What is Emtri used for?

A: Emtri is a three-component medication that effectively treats HIV-1 infection in adults. Although Emtri cannot treat HIV-1 completely, it is able to decrease the viral load in your blood and keep infection under control, preventing other HIV-related diseases. Emtri is not suitable for patients under 18 years of age.

Q: Is Emtri safe?

A: Emtri is safe if taken as prescribed by your doctor.

Q: Is Emtri safe during pregnancy?

A: Consult your doctor before taking Emtri if you are pregnant or plan to have a baby.

Target Point Shipping Method Tracking Delivery Time Price
Worldwide Shipping

Worldwide Shipping

Registered Mail  Not trackable 14-21 business days USD 15.00 per order
EMS  Trackable, where available 5-9 business days USD 25.00 per order

Delivery time is:

Registered Mail - 14-21 business days, price - USD 15.00, no signature is required on delivery.
EMS - 5-9 business days, price - USD 25.00, signature is required on delivery.
Your order will be packed safe and secure and dispatched within 24 hours.

front back side

This is exactly how your parcel will look like (pictures of a real shipping item). It has a look of a regular private letter and does not disclose its contents. Size - 9.4x4.3x0.3 inches (24x11x0.7cm).

Other Proposition Protection Status